Qualitative user evaluation of a revised pharmacogenetic educational toolkit

Rachel Mills, Susanne B Haga Duke Center for Applied Genomics and Precision Medicine, Duke University Medical Center, Durham, NC, USA Introduction: Pharmacogenetic (PGx) testing is a leading application for personalized and precision medicine; however, there are barriers, including limited provider...

Full description

Bibliographic Details
Main Authors: Mills R, Haga SB
Format: Article
Language:English
Published: Dove Medical Press 2018-09-01
Series:Pharmacogenomics and Personalized Medicine
Subjects:
Online Access:https://www.dovepress.com/qualitative-user-evaluation-of-a-revised-pharmacogenetic-educational-t-peer-reviewed-article-PGPM
id doaj-5b500800f45e41f2b45a3667192d6d0d
record_format Article
spelling doaj-5b500800f45e41f2b45a3667192d6d0d2020-11-25T00:54:28ZengDove Medical PressPharmacogenomics and Personalized Medicine1178-70662018-09-01Volume 1113914640302Qualitative user evaluation of a revised pharmacogenetic educational toolkitMills RHaga SBRachel Mills, Susanne B Haga Duke Center for Applied Genomics and Precision Medicine, Duke University Medical Center, Durham, NC, USA Introduction: Pharmacogenetic (PGx) testing is a leading application for personalized and precision medicine; however, there are barriers, including limited provider and patient understanding, which affect its uptake. There is a need for tools that can enhance the patient and provider experience with testing and promoting the shared and informed decision-making. Materials and methods: In this study, we sought to gather additional feedback on a PGx toolkit comprised of four educational tools that had been previously evaluated through an online survey by pharmacists. Specifically, we conducted semi-structured interviews with pharmacists and members of the public regarding their understanding and utility of the toolkit and its individual components. Results: Participants found three of the four toolkit components, a test information sheet, flipbook, and results sheet, to be useful and important. The fourth component, results card, was viewed less favorably. Participants differed in their preference for medical jargon and detailed results nomenclature (namely star * alleles). Conclusion: User input during the development of educational materials is essential for optimizing utilization, effectiveness, and comprehension. Keywords: pharmacogenetic testing, pharmacogenomics, patient education, community pharmacisthttps://www.dovepress.com/qualitative-user-evaluation-of-a-revised-pharmacogenetic-educational-t-peer-reviewed-article-PGPMpharmacogenomicspharmacogenetic testingeducational toolspatient educationpharmacist interviews
collection DOAJ
language English
format Article
sources DOAJ
author Mills R
Haga SB
spellingShingle Mills R
Haga SB
Qualitative user evaluation of a revised pharmacogenetic educational toolkit
Pharmacogenomics and Personalized Medicine
pharmacogenomics
pharmacogenetic testing
educational tools
patient education
pharmacist interviews
author_facet Mills R
Haga SB
author_sort Mills R
title Qualitative user evaluation of a revised pharmacogenetic educational toolkit
title_short Qualitative user evaluation of a revised pharmacogenetic educational toolkit
title_full Qualitative user evaluation of a revised pharmacogenetic educational toolkit
title_fullStr Qualitative user evaluation of a revised pharmacogenetic educational toolkit
title_full_unstemmed Qualitative user evaluation of a revised pharmacogenetic educational toolkit
title_sort qualitative user evaluation of a revised pharmacogenetic educational toolkit
publisher Dove Medical Press
series Pharmacogenomics and Personalized Medicine
issn 1178-7066
publishDate 2018-09-01
description Rachel Mills, Susanne B Haga Duke Center for Applied Genomics and Precision Medicine, Duke University Medical Center, Durham, NC, USA Introduction: Pharmacogenetic (PGx) testing is a leading application for personalized and precision medicine; however, there are barriers, including limited provider and patient understanding, which affect its uptake. There is a need for tools that can enhance the patient and provider experience with testing and promoting the shared and informed decision-making. Materials and methods: In this study, we sought to gather additional feedback on a PGx toolkit comprised of four educational tools that had been previously evaluated through an online survey by pharmacists. Specifically, we conducted semi-structured interviews with pharmacists and members of the public regarding their understanding and utility of the toolkit and its individual components. Results: Participants found three of the four toolkit components, a test information sheet, flipbook, and results sheet, to be useful and important. The fourth component, results card, was viewed less favorably. Participants differed in their preference for medical jargon and detailed results nomenclature (namely star * alleles). Conclusion: User input during the development of educational materials is essential for optimizing utilization, effectiveness, and comprehension. Keywords: pharmacogenetic testing, pharmacogenomics, patient education, community pharmacist
topic pharmacogenomics
pharmacogenetic testing
educational tools
patient education
pharmacist interviews
url https://www.dovepress.com/qualitative-user-evaluation-of-a-revised-pharmacogenetic-educational-t-peer-reviewed-article-PGPM
work_keys_str_mv AT millsr qualitativeuserevaluationofarevisedpharmacogeneticeducationaltoolkit
AT hagasb qualitativeuserevaluationofarevisedpharmacogeneticeducationaltoolkit
_version_ 1725234315437015040